BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19103853)

  • 1. Neonatal haemoglobinopathy screening in Spain.
    Mañú Pereira M; Corrons JL
    J Clin Pathol; 2009 Jan; 62(1):22-5. PubMed ID: 19103853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal/newborn haemoglobinopathy screening in Europe and Africa.
    Bain BJ
    J Clin Pathol; 2009 Jan; 62(1):53-6. PubMed ID: 19103862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with alpha thalassemia and G6PD deficiency].
    Mañú Pereira Mdel M; Cabot A; Martínez González A; Sitjà Navarro E; Cararach V; Sabrià J; Boixaderas J; Teixidor R; Bosch A; López Vílchez MA; Martín Ibáñez I; Carrión T; Plaja P; Sánchez M; Vives Corrons JL
    Med Clin (Barc); 2007 Jun; 129(5):161-4. PubMed ID: 17669331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal screening for sickle cell disease in France.
    Bardakdjian-Michau J; Bahuau M; Hurtrel D; Godart C; Riou J; Mathis M; Goossens M; Badens C; Ducrocq R; Elion J; Perini JM
    J Clin Pathol; 2009 Jan; 62(1):31-3. PubMed ID: 19103855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal screening for sickle cell disease and other hemoglobinopathies in "the changing Europe".
    Rolla R; Castagno M; Zaffaroni M; Grigollo B; Colombo S; Piccotti S; Dellora C; Bona G; Bellomo G
    Clin Lab; 2014; 60(12):2089-93. PubMed ID: 25651745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case study of haemoglobinopathy screening in the Netherlands: witnessing the past, lessons for the future.
    Jans SM; van El CG; Houwaart ES; Westerman MJ; Janssens RJ; Lagro-Janssen AL; Plass AM; Cornel MC
    Ethn Health; 2012; 17(3):217-39. PubMed ID: 21819310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology Guideline.
    Bain BJ; Daniel Y; Henthorn J; de la Salle B; Hogan A; Roy NBA; Mooney C; Langabeer L; Rees DC;
    Br J Haematol; 2023 Jun; 201(6):1047-1065. PubMed ID: 37271570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels.
    Gulbis B; Ferster A; Cotton F; Lebouchard MP; Cochaux P; Vertongen F
    J Med Screen; 2006; 13(2):76-8. PubMed ID: 16792829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.
    García-Morín M; Bardón-Cancho EJ; Beléndez C; Zamarro R; Béliz-Mendiola C; González-Rivera M; Vecilla C; Llorente-Otones L; Pérez-Alonso V; Román SS; Sebastián E; Dulín E; Cela E
    Ann Hematol; 2020 Jul; 99(7):1465-1474. PubMed ID: 32451712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemoglobinopathies and newborn haemoglobinopathy screening in Germany.
    Dickerhoff R; Genzel-Boroviczeny O; Kohne E
    J Clin Pathol; 2009 Jan; 62(1):34. PubMed ID: 19103856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population estimates of sickle cell disease in the U.S.
    Hassell KL
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S512-21. PubMed ID: 20331952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy.
    Ballardini E; Tarocco A; Marsella M; Bernardoni R; Carandina G; Melandri C; Guerra G; Patella A; Zucchelli M; Ferlini A; Bigoni S; Ravani A; Garani G; Borgna-Pignatti C
    Blood Transfus; 2013 Apr; 11(2):245-9. PubMed ID: 23058858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costing model for neonatal screening and diagnosis of haemoglobinopathies.
    Cronin EK; Normand C; Henthorn JS; Hickman M; Davies SC
    Arch Dis Child Fetal Neonatal Ed; 1998 Nov; 79(3):F161-7. PubMed ID: 10194984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of the Spanish registry of haemoglobinopathies in children and adults.
    Bardón Cancho EJ; García-Morín M; Beléndez C; Velasco P; Benéitez D; Ruiz-Llobet A; Berrueco R; Argilés B; Cervera Á; Salinas JA; Vecilla C; Gondra A; Vallés G; Murciano T; Bermúdez M; Cela E;
    Med Clin (Barc); 2020 Aug; 155(3):95-103. PubMed ID: 32113697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
    Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
    Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
    Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neonatal screening of hemoglobinopathies and glucose-6-phosphate dehydrogenase in Catalonia. Pilot study in anonymous not related population].
    Mañú-Pereira Mdel M; Maya A; Cararach V; Sabrià J; Boixadera J; Quintó L; Vives-Corrons JL
    Med Clin (Barc); 2006 Mar; 126(8):281-5. PubMed ID: 16527153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening.
    Peters M; Fijnvandraat K; van den Tweel XW; Garre FG; Giordano PC; van Wouwe JP; Pereira RR; Verkerk PH
    Arch Dis Child; 2010 Oct; 95(10):822-5. PubMed ID: 20576657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle cell disease: time for a targeted neonatal screening programme.
    Gibbons C; Geoghegan R; Conroy H; Lippacott S; O'Brien D; Lynam P; Langabeer L; Cotter M; Smith O; McMahon C
    Ir Med J; 2015 Feb; 108(2):43-5. PubMed ID: 25803954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.